NCT06577519View on ClinicalTrials.gov

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Interventions
DRUG

Vicagrel

Vicagrel loading followed by Maintenance dose

DRUG

Clopidogrel

Clopidogrel loading followed by Maintenance dose

Trial Locations (1)

110015

RECRUITING

General Hospital of Northern Theater Command of Chinese PLA, Shenyang

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY